Category Archives: Market Dynamics

Congress’ Drug Addiction

Posted 2/26/16 on Employee Benefit News. The Congressional committee that recently demanded Martin Shkreli’s appearance must have hoped to spotlight a smug jerk responsible for the outrageous prescription drug pricing that we’re all up against. Of course there are lots of … Continue reading

Rate this:

Posted in Benefits, Brian Klepper, Conflicts of Interest, Health Care Cost, Market Dynamics, Medical Management, Policy/Law/Regulation, Politics, Quality | Tagged , , , , | 9 Comments

Why Does The FDA Approve Cancer Drugs That Don’t Work

BRIAN KLEPPER Posted 10/23/15 on The Health Care Blog A new study in JAMA Internal Medicine finds that two-thirds of cancer drugs considered by the US Food and Drug Administration (FDA) over the past five years were approved without evidence that … Continue reading

Rate this:

Posted in Analytics, Brian Klepper, Conflicts of Interest, Health Care Cost, Innovation, Life Sciences, Market Dynamics, Policy/Law/Regulation | Tagged , , | 3 Comments

Will Specialty Drug Pricing Be The Straw?

Published 5/27/15 in Employee Benefit News Over the next few years, drug manufacturers will release a host of new drugs that are more complex and, in many cases, more effective than we’ve had access to in the past. There will be … Continue reading

Rate this:

Posted in Analytics, Benefits, Brian Klepper, Health Care Cost, Innovation, Life Sciences, Market Dynamics, Medical Management, Policy/Law/Regulation, Politics, Quality | Tagged , , | Leave a comment

How Business Can Save America from Health Care

Brian Klepper Published 6/09/14 in Employee Benefit News One of America’s most enduring mysteries is why the organizations that pay for most health care don’t work together to force better value from the health care industry. We pay double for health … Continue reading

Rate this:

Posted in Analytics, Benefits, Brian Klepper, Conflicts of Interest, Health Care Cost, Market Dynamics, Medical Management, Policy/Law/Regulation, Politics | Tagged , , | 5 Comments

Getting Beyond Fee-For-Service

Brian Klepper Posted 12/02/13 on Medscape Connect’s Care and Cost Blog The catchy title of a recent Harvard Business Review Blog post, The Big Barrier To High Value Health Care: Destructive Self-Interest, suggested that the Institute for Healthcare Improvement (IHI) is forging arrangements … Continue reading

Rate this:

Posted in Benefits, Brian Klepper, Conflicts of Interest, Market Dynamics, Medical Management, Physicians, Policy/Law/Regulation, Politics, Quality, Tools | Tagged , , , , | 6 Comments

Facilitating Interoperability

October 18th, 2013 Cross-Posted 10/18/13 from The Health Affairs Blog A Health Affairs report on health information interoperability by staffers of the Office of the National Coordinator for Health Information Technology (ONC) provides a good enough summary of the situation. But it also is not … Continue reading

Rate this:

Posted in Analytics, Health Care Cost, Health IT, Market Dynamics, Medical Management, Policy/Law/Regulation, Politics, Quality | Tagged , , , , | 2 Comments

A Better Way To Manage Care and Cost

Brian Klepper http://boards.medscape.com/forums?128@864.cQ5Savfkkqo@.2a59c1b3!comment=1  Posted 10/10/12 on Medscape Connect’s Care & Cost Blog When an employer sits down with his health care partners – broker, health plan, physician, hospital, drug and device firm, health IT firm – everyone but him wants health … Continue reading

Rate this:

Posted in Analytics, Benefits, Conflicts of Interest, Health Care Cost, Market Dynamics, Medical Management, Physicians, Policy/Law/Regulation, Politics, Quality, Reform | Tagged , , , , , , , , | 4 Comments

Why Employers Must Collaborate On Health Care

Brian Klepper Published in the Columbus, GA Ledger-Enquirer on Sunday, 9/15/13 I recently was privileged to deliver a keynote at the Greater Columbus Chamber’s Healthcare Symposium. I get invited to meetings like this around the country because I lay out … Continue reading

Rate this:

Posted in Analytics, Benefits, Brian Klepper, Conflicts of Interest, Health Care Cost, Market Dynamics, Medical Management, Physicians, Policy/Law/Regulation, Politics, Quality, Reform | Tagged , , , , | Leave a comment

The RUC (Again): Is there a Light at the End of the Tunnel? A Conversation with Brian Klepper

David Harlow Posted August 13, 2013 on HealthBlawg Recently, there were a couple of breathless articles about the RUC (Relative Value Scale Update Committee) published in The Washington Post and The Washington Monthly, reporting as news the state of affairs that has prevailed … Continue reading

Rate this:

Posted in Analytics, Brian Klepper, Conflicts of Interest, Health Care Cost, Market Dynamics, Medical Management, Physicians, Policy/Law/Regulation, Politics, Quality, Reform | Tagged , , , , , , | 2 Comments

DOTmed – An Interview with Brian Klepper

Loren Bonner , DOTmed News Online Editor August 15, 2013 DMN: After Steven Brill’s blockbuster article in Time Magazine came out a few months ago, it feels like everyone is interested to know the real scoop on hospital pricing and what’s … Continue reading

Rate this:

Posted in Analytics, Brian Klepper, Conflicts of Interest, Health Care Cost, Imaging, Innovation, Market Dynamics, Medical Management, Physicians, Policy/Law/Regulation, Quality, Reform | Tagged , , , | 1 Comment

The RUC Is Bad Medicine: It Has To Go

Brian Klepper Posted 8/12/13 on Medscape Business of Medicine “One of the biggest mistakes we made … is that we took the RUC … back in 1992 and gave it to the AMA. … It’s incredibly political, and it’s just … Continue reading

Rate this:

Posted in Analytics, Brian Klepper, Conflicts of Interest, Health Care Cost, Market Dynamics, Physicians, Policy/Law/Regulation, Politics, Quality, Reform | Tagged , , , , , , , , , , , , , , , , , , , , , , | 2 Comments

How TPAs Can Win

Brian Klepper Published August 1, 2013 in the Self-Insurer One of health care’s deeper mysteries is why third party administration (TPA) firms remain minor health plan players and, to a large degree, have been all but uncompetitive with the major … Continue reading

Rate this:

Posted in Analytics, Benefits, Brian Klepper, Conflicts of Interest, Health Care Cost, Innovation, Market Dynamics, Medical Management, Quality | Tagged , , , , , | Leave a comment

Why Congress Should Pass The Accuracy In Medicare Physician Payment Act

Brian Klepper and Paul Fischer Posted 8/09/13 on The Health Affairs Blog With the recent release of two mainstream exposes, one in the Washington Post and another in the Washington Monthly, the American Medical Association’s (AMA) medical procedure valuation franchise, the Relative Value … Continue reading

Rate this:

Posted in Analytics, Brian Klepper, Conflicts of Interest, Health Care Cost, Innovation, Market Dynamics, Physicians, Policy/Law/Regulation, Politics, Quality | Tagged , , , , , | Leave a comment

Hurtling Down the Road to Ruin

Brian Klepper and David C. Kibbe Posted 6/21/13 on Medscape Internal Medicine A recent New York Times article that focused on colonoscopies highlighted the questionable science, predatory unit pricing, and overutilization that characterize this procedure and much of US healthcare. Patients get routine … Continue reading

Rate this:

Posted in Benefits, Brian Klepper, Conflicts of Interest, Health Care Cost, Market Dynamics, Medical Management, Policy/Law/Regulation, Politics | Tagged , , , , , , , , , | 2 Comments

Physicians, Health Systems and the Drive For Market Dominance

Brian Klepper Posted 5/23/13 on Medscape Connect’s Care & Cost Blog Several physicians have reached out recently to discuss attractive employment offers from health systems. They are invariably conflicted. They understand the trade-offs, that they’ll give up the autonomy they’ve … Continue reading

Rate this:

Posted in Health Care Cost, Innovation, Market Dynamics, Medical Management, Physicians, Policy/Law/Regulation, Politics, Quality, Reform | Tagged , , , , , , , , | 2 Comments